Health & Environmental Research Online (HERO)


Print Feedback Export to File
5063958 
Journal Article 
Exploring sex differences in human health risk assessment for PFNA and PFDA using a PBPK model 
Kim, SJ; Choi, EJ; Choi, GW; Lee, YB; Cho, HY 
2019 
Yes 
Archives of Toxicology
ISSN: 0340-5761
EISSN: 1432-0738 
SPRINGER HEIDELBERG 
HEIDELBERG 
93 
311-330 
English 
has comment/response 5412088 Comment on 'Kim, S.-J., Choi, E.-J., Choi, G.-W., Lee, Y.-B., and Cho, H.-Y. (2019)., Arch Toxicol 93:311-330'
Perfluorononanoic acid (PFNA) and perfluorodecanoic acid (PFDA), which are classified as perfluoroalkyl and polyfluoroalkyl substances (PFASs), have been widely used in industrial applications as a surface protectant. PFASs have been detected in wildlife and in humans around the globe. The purposes of this study are to develop and validate a physiologically based pharmacokinetic (PBPK) model for detecting PFNA and PFDA in male and female rats, and to apply the model to a human health risk assessment regarding the sex difference. A PBPK model of PFNA and PFDA was established based on an in vivo study in male and female rats. Analytes in biological samples (plasma, nine tissues, urine, and feces) were determined by ultra-liquid chromatography coupled tandem mass spectrometry (UPLC-MS/MS) method. PFNA and PFDA showed a gender differences in the elimination half-life and volume of distribution. The tissue-plasma partition coefficients were the highest in the liver in both male and female rats. The predicted rat plasma and urine concentrations simulated and fitted were in good agreement with the observed values. The PBPK models of PFNA and PFDA in male and female rats were then extrapolated to a human PBPK model based on human physiological parameters. The external doses were calculated at 3.35 ng/kg/day (male) and 17.0 ng/kg/day (female) for PFNA and 0.530 ng/kg/day (male) and 0.661 ng/kg/day (female) for PFDA. Human risk assessment was estimated using Korean biomonitoring values considering the gender differences. This study provides valuable insight into human health risk assessment regarding PFNA and PFDA exposure. 
Environmental Studies--Toxicology And Environmental Safety; Perfluorononanoic acid (PFNA); Perfluorodecanoic acid (PFDA); Human health risk assessment; Gender differences; Mass spectrometry; Liquid chromatography; Analytical chemistry; Pharmacology; Biological properties; Biomonitoring; Risk assessment; Animal models; Perfluorodecanoic acid; Perfluoro compounds; In vivo methods and tests; Rodents; Computer simulation; Biological samples; Gender aspects; Sex differences; Industrial applications; Perfluoroalkyls; Tissues; Wildlife; Health risk assessment; Mass spectroscopy; Health risks 
PFAS
• Additional PFAS (formerly XAgency)
• PFAS 150
     Literature Search August 2019
          PubMed
          Web of Science
     Not prioritized for screening
     Perfluorodecanoic acid
     Perfluorononanoic acid
     Perfluorooctanoic acid
• PFBA
     Protocol References
• PFBS
• PFDA
     Literature Search
          Pubmed
     Literature Search Update 5/2019
          PubMed
     Literature Search Update 4/2021
          WoS
     Scopus: April 2021
     Title and Abstract Screening
          Full Text Screening
               Studies Meeting PECO
                    PBPK models
     Literature Searches (through April 2023 update and post-public comment/peer review)a    
          Title & Abstract Screening
               Tagged as Supplemental
                    Full Text Screening
                         Studies Meeting PECO
                              PBPK models
• PFHxA
     HAWC
• PFHxS
• PFNA
     Literature Search
          Pubmed
          WOS
     PFNA May 2019 Update
          Pubmed
          Web of Science
     LitSearch: May 2019 - May 2020
          WoS
     Title and Abstract Screening
          Full Text Screening
               Studies Meeting PECO
                    Animal health effects studies
                    PBPK models
• PFOA (335-67-1) and PFOS (1763-23-1)
     Literature Search Update (2013-2019)
          WOS
• Yale PFAS Liver study